Epididymo-orchitis is inflammation, usually infection, of the epididymis and testis. Inflammation limited to the epididymis is called epididymitis. - Bailey and Love's Short Practice of Surgery, 28th ed., section “Epididymo-orchitis”
Typical features
- Gradually worsening, usually one-sided scrotal pain, swelling, warmth and tenderness
- Fever, burning urination, urinary frequency, urethral discharge, or lower abdominal pain may occur
- The epididymis is affected first and infection can extend to the testis.
Common causes
- Sexually active younger men: commonly Chlamydia trachomatis or Neisseria gonorrhoeae
- Older men, urinary obstruction, catheter/instrumentation: urinary bacteria, often enteric organisms such as E. coli
- Less commonly: viral orchitis, including mumps, tuberculosis, or other infections.
Diagnosis
A clinician should examine the scrotum and usually perform:
- Urine analysis and urine culture
- Urine NAAT testing for chlamydia and gonorrhea where relevant
- Scrotal Doppler ultrasound if testicular torsion cannot be confidently excluded, or if abscess is suspected.
Testicular torsion must be ruled out urgently. Sudden severe testicular pain, high-riding or abnormally positioned testis, nausea/vomiting, or pain beginning within hours warrants emergency assessment now. Torsion can threaten testicular viability within hours.
Treatment
Treatment depends on the likely organism and local resistance guidance. It generally includes:
- Prescribed antibiotics
- Rest, scrotal elevation/support, ice packs
- Anti-inflammatory pain medication if safe for you
- Treatment and testing of sexual partners if an STI is suspected
- Avoid sex until treatment is complete, symptoms have resolved, and partners have been managed.
For suspected STI-associated infection, the
CDC epididymitis guidance recommends ceftriaxone plus doxycycline; regimens differ when enteric urinary organisms are likely. Antibiotics should be selected by a clinician rather than self-started.
Seek urgent care if there is severe pain, high fever, vomiting, rapidly increasing swelling/redness, inability to pass urine, or no improvement within 48-72 hours of starting treatment.